Cardiovascular and renal hemodynamic effects of intravenous infusions of the selective DA1 agonist, fenoldopam, used alone or in combination with dopamine and dobutamine.
- 1 November 1988
- journal article
- abstracts
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 78 (5), 1310-1315
- https://doi.org/10.1161/01.cir.78.5.1310
Abstract
Fenoldopam (0.1 and 0.2 microgram/kg/min i.v.) was administered to pentobarbital-anesthetized dogs alone and combined with dopamine (DA) and dobutamine. Renal blood flow, heart rate, and mean arterial pressure were measured. Both dosages of fenoldopam increased renal blood flow without altering blood pressure, similar to the effects of DA (1 and 2 micrograms/kg/min). Administration of fenoldopam with only DA (1 microgram/kg/min) produced further increase in renal blood flow. After administration of phenoxybenzamine (15 mg/kg i.v.), DA produced significant increments in renal blood flow and reductions in renal vascular resistance when compared with experiments without phenoxybenzamine, suggesting even low dosages of DA exert alpha-adrenoceptor agonist activity. Dobutamine (2 and 4 micrograms/kg/min) increased renal blood flow about 37% of that produced by DA. Fenoldopam added to dobutamine produced similar increments in renal blood flow as DA. Fenoldopam did not affect the increase in cardiac contractile force produced by DA and dobutamine. Thus, fenoldopam alone or in combination with DA had no advantage over 2 and 4 micrograms/kg/min DA to further increase renal blood flow. In contrast, fenoldopam with dobutamine produced greater increments in cardiac contractile force than DA and equivalent increases in renal blood flow as DA.Keywords
This publication has 14 references indexed in Scilit:
- Selective dopamine-1 agonist therapy in severe hypertension: Effects of intravenous fenoldopamJournal of the American College of Cardiology, 1988
- Intravenous fenoldopam in heart failure: Comparing the hemodynamic effects of dopamine1 receptor agonism with nitroprussideAmerican Heart Journal, 1988
- Relative DA1-Dopamine-Receptor Agonist and α-Adrenoceptor Antagonist Activity of Fenoldopam in the Anesthetized DogJournal of Cardiovascular Pharmacology, 1988
- Hemodynamic effects of an oral dopamine receptor agonist (fenoldopam) in patients with congestive heart failureJournal of the American College of Cardiology, 1985
- The Diuretic Properties of Dopamine in Patients after Open-heart OperationAnesthesiology, 1984
- Dopamine administration in oliguria and oliguric renal failureCritical Care Medicine, 1981
- DOPAMINE HYDROCHLORIDE IN OLIGURIC STATESThe Lancet, 1980
- Dobutamine: A New Synthetic Cardioactive Sympathetic AmineNew England Journal of Medicine, 1979
- Comparative systemic and regional hemodynamic effects of dopamine and dobutamineAmerican Heart Journal, 1975
- Effects of Dopamine in Man: Augmentation of Sodium Excretion, Glomerular Filtration Rate, and Renal Plasma Flow*JCI Insight, 1964